NOVITIUM PHARMA LLC.
US H-1B Labor Condition Application activity for NOVITIUM PHARMA LLC.. Filed 333 disclosures between FY2017 and FY2026 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of NOVITIUM PHARMA LLC.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 92.2% |
| Withdrawn | 7.2% |
| Denied | 0.6% |
Top occupations sponsored
SOC codes filed most by NOVITIUM PHARMA LLC. across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2031 | Chemists | 149 |
| 2 | 15-1253 | Software Quality Assurance Analysts and Testers | 69 |
| 3 | 13-1041 | Compliance Officers | 29 |
| 4 | 19-2012 | Physicists | 10 |
| 5 | 11-3021 | Computer and Information Systems Managers | 6 |
| 6 | 17-2141 | Mechanical Engineers | 6 |
| 7 | 19-1021 | Biochemists and Biophysicists | 4 |
| 8 | 11-3051 | Industrial Production Managers | 4 |
| 9 | 17-2112 | Industrial Engineers | 3 |
| 10 | 19-1022 | Microbiologists | 2 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2017 | 49 |
| FY2018 | 63 |
| FY2019 | 43 |
| FY2020 | 1 |
| FY2021 | 3 |
| FY2022 | 1 |
| FY2023 | 2 |
| FY2024 | 81 |
| FY2025 | 81 |
| FY2026 | 9 |
| Period | Value |
|---|---|
| FY2017 | 49 |
| FY2018 | 63 |
| FY2019 | 43 |
| FY2020 | 1 |
| FY2021 | 3 |
| FY2022 | 1 |
| FY2023 | 2 |
| FY2024 | 81 |
| FY2025 | 81 |
| FY2026 | 9 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.